Literature DB >> 11091281

Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.

A Prasse1, C G Georges, H Biller, H Hamm, H Matthys, W Luttmann, J C Virchow.   

Abstract

The pathogenesis of pulmonary sarcoidosis has been related to an increased production of Th1-like cytokines. However, cytokine expression in sarcoidosis has not been systematically studied at a single-cell level. We therefore investigated the expression of IL-2, IL-4, IL-13, tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) intracellularly in bronchoalveolar lavage (BAL) and peripheral blood CD3+ T lymphocytes from patients with pulmonary sarcoidosis (radiologic stage II-III, n = 8) and normal controls (n = 9) by flow cytometry. In contrast to IL-4 and IL-13, the percentage of T lymphocytes expressing intracellular IL-2 (49.3 +/- 21.3% versus 14.5 +/- 15.6%), IFN-gamma (75.5 +/- 14.9% versus 32.6 +/- 18.7%) and TNF-alpha (68.3 +/- 18.7% versus 36.8 +/- 20.8%) was significantly higher in patients with sarcoidosis than in normal controls (each P < 0.005). In contrast to BAL lymphocytes, expression of these cytokines in peripheral blood lymphocytes did not differ between patients with sarcoidosis and normal controls. Close correlations were observed between the percentages of BAL lymphocytes expressing intracellular IL-2, IFN-gamma and TNF-alpha, but not for IL-4 or IL-13. Analysis of the expression of these cytokines in T lymphocyte subsets revealed IL-2, IFN-gamma, and TNF-alpha in CD4+ as well as CD8+ T lymphocytes, suggesting a contribution of TC1 cells to the production of proinflammatory cytokines in sarcoidosis. We conclude that a Th1-like cytokine pattern can be observed in CD4+ as well as in CD8+ BAL T lymphocytes in patients with pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091281      PMCID: PMC1905777          DOI: 10.1046/j.1365-2249.2000.01365.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10.

Authors:  B R Lúdvíksson; M C Sneller; K S Chua; C Talar-Williams; C A Langford; R O Ehrhardt; A S Fauci; W Strober
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

2.  The relationship between disease duration and noninvasive pulmonary explorations in sarcoidosis with erythema nodosum.

Authors:  D Valeyre; G Saumon; R Georges; J L Kemeny; D Bladier; J Amouroux; J Pré; J P Battesti
Journal:  Am Rev Respir Dis       Date:  1984-06

3.  Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  P Pinkston; P B Bitterman; R G Crystal
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

4.  Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

Authors:  K Ward; C O'Connor; C Odlum; M X Fitzgerald
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

5.  Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis.

Authors:  G W Hunninghake; G N Bedell; D C Zavala; M Monick; M Brady
Journal:  Am Rev Respir Dis       Date:  1983-10

6.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

7.  Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.

Authors:  M Steffen; O G Ottmann; M A Moore
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

8.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

9.  Human T cells from autoimmune and normal individuals can produce tumor necrosis factor.

Authors:  M Turner; M Londei; M Feldmann
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

10.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

View more
  37 in total

1.  Uveitis associated with sarcoidosis exacerbated by etanercept therapy.

Authors:  Jun Suzuki; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

2.  The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.

Authors:  Karthik Suresh; Jarushka Naidoo; Qiong Zhong; Ye Xiong; Jennifer Mammen; Marcia Villegas de Flores; Laura Cappelli; Aanika Balaji; Tsvi Palmer; Patrick M Forde; Valsamo Anagnostou; David S Ettinger; Kristen A Marrone; Ronan J Kelly; Christine L Hann; Benjamin Levy; Josephine L Feliciano; Cheng-Ting Lin; David Feller-Kopman; Andrew D Lerner; Hans Lee; Majid Shafiq; Lonny Yarmus; Evan J Lipson; Mark Soloski; Julie R Brahmer; Sonye K Danoff; Franco D'Alessio
Journal:  J Clin Invest       Date:  2019-07-16       Impact factor: 14.808

3.  Macrophage Polarization in Sarcoidosis: An Unexpected Accomplice?

Authors:  Theodore J Standiford
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

4.  Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.

Authors:  Nicholas K Arger; Melissa Ho; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-04-17       Impact factor: 3.415

5.  Induction of Pulmonary Granuloma Formation by Propionibacterium acnes Is Regulated by MyD88 and Nox2.

Authors:  Jessica L Werner; Sylvia G Escolero; Jeff T Hewlett; Tim N Mak; Brian P Williams; Yoshinobu Eishi; Gabriel Núñez
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

Review 6.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

7.  Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab.

Authors:  D Dragnev; D Barr; M Kulshrestha; S Shanmugalingam
Journal:  BMJ Case Rep       Date:  2013-09-04

8.  The anergic state in sarcoidosis is associated with diminished dendritic cell function.

Authors:  Sneha Mathew; Kristy L Bauer; Arne Fischoeder; Nina Bhardwaj; Stephen J Oliver
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.

Authors:  T Kurumagawa; S Seki; H Kobayashi; Y Koike; S Kanoh; H Hiraide; K Motoyoshi
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Increased interleukin-13 expression in patients with sarcoidosis.

Authors:  H-P Hauber; D Gholami; A Meyer; A Pforte
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.